Account

Sign in to access your account and subscription

Software Review: Needles Case Management Software

Javerbaum Wurgaft Hicks & Zarin is a tort litigation firm based in Springfield, NJ. The firm consists of six partners, associate attorneys, and support staff. We have used the Needles Case Management Software System since 1991 (at that time, it was called PINS, which was the DOS-based version of the program). The firm, at the time, was looking for a program that would organize the office and streamline casework. We were swamped with paper files and though we had a case flow, it was disorganized. Today, with 20 people in the office using the Needles program to manage cases, our firm is more organized than ever before.

12 minute read August 30, 2005 at 10:44 AM
By
Robert Hicks
Software Review: Needles Case Management Software

Javerbaum Wurgaft Hicks & Zarin is a tort litigation firm based in Springfield, NJ. The firm consists of six partners, associate attorneys, and support staff.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

The Copyright Royalty Board (CRB), which works under the umbrella of the Librarian of Congress, sets statutory-license royalty terms and rates. The U.S. Courts of Appeals for the D.C. Circuit recently issued two notable decisions about the CRB.

October 01, 2026